Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Amazon
AMZN
|
+$529M |
| 2 |
Apple
AAPL
|
+$498M |
| 3 |
Procter & Gamble
PG
|
+$497M |
| 4 |
Elanco Animal Health
ELAN
|
+$467M |
| 5 |
AbbVie
ABBV
|
+$397M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$696M |
| 2 |
Intuit
INTU
|
+$535M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$503M |
| 4 |
Intercontinental Exchange
ICE
|
+$459M |
| 5 |
Boeing
BA
|
+$420M |
Sector Composition
| 1 | Technology | 28.58% |
| 2 | Healthcare | 18.93% |
| 3 | Financials | 10.61% |
| 4 | Consumer Discretionary | 10.26% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Atkore
ATKR
$1.93B
| $304K | ﹤0.01% |
14,411
+4,338
| +43% | +$91.5K |
|
1227
BlackBerry
BB
$2.25B
| $304K | ﹤0.01% |
74,906
| – | – |
|
1228
Blue Owl Capital
OBDC
$7.28B
| $303K | ﹤0.01% |
26,288
-14,448
| -35% | -$167K |
|
|
UN
1229
DELISTED
Unilever NV New York Registry Shares
UN
| $300K | ﹤0.01% |
6,153
| – | – |
|
1230
HF Foods Group
HFFG
$171M
| $299K | ﹤0.01% |
35,604
+12,269
| +53% | +$103K |
|
|
COR
1231
DELISTED
Coresite Realty Corporation
COR
| $298K | ﹤0.01% |
2,571
-4,724
| -65% | -$548K |
|
1232
National Grid
NGG
$69.6B
| $291K | ﹤0.01% |
+5,574
| New | +$291K |
|
1233
LCI Industries
LCII
$2.5B
| $289K | ﹤0.01% |
4,321
+364
| +9% | +$24.3K |
|
1234
Banco Macro
BMA
$2.93B
| $288K | ﹤0.01% |
+16,947
| New | +$288K |
|
1235
ASGN Inc
ASGN
$2.32B
| $284K | ﹤0.01% |
8,049
+2,660
| +49% | +$93.9K |
|
1236
Ollie's Bargain Outlet
OLLI
$7.85B
| $283K | ﹤0.01% |
6,097
-641,904
| -99% | -$29.8M |
|
|
ABB
1237
DELISTED
ABB Ltd.
ABB
| $281K | ﹤0.01% |
+16,309
| New | +$281K |
|
1238
Fox Factory Holding Corp
FOXF
$1.22B
| $279K | ﹤0.01% |
6,651
-817,124
| -99% | -$34.3M |
|
1239
Addus HomeCare
ADUS
$2.07B
| $278K | ﹤0.01% |
4,115
+111
| +3% | +$7.5K |
|
|
RDS.B
1240
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $267K | ﹤0.01% |
8,168
-1,621
| -17% | -$53K |
|
1241
American Airlines Group
AAL
$8.49B
| $262K | ﹤0.01% |
21,535
-5,013
| -19% | -$61K |
|
1242
National Healthcare
NHC
$1.75B
| $250K | ﹤0.01% |
3,484
-116
| -3% | -$8.32K |
|
|
DHC
1243
Diversified Healthcare Trust
DHC
$1.03B
| $246K | ﹤0.01% |
+67,680
| New | +$246K |
|
1244
Pennant Group
PNTG
$850M
| $242K | ﹤0.01% |
17,061
-6,193
| -27% | -$87.8K |
|
1245
Bio-Rad Laboratories Class A
BIO
$7.83B
| $238K | ﹤0.01% |
+680
| New | +$238K |
|
1246
Corcept Therapeutics
CORT
$7.46B
| $236K | ﹤0.01% |
19,890
-46,434
| -70% | -$551K |
|
|
AVTR.PRA
1247
DELISTED
Avantor, Inc. Series A Mandatory Convertible Preferred Stock
AVTR.PRA
| $236K | ﹤0.01% |
5,250
| – | – |
|
1248
American Woodmark
AMWD
$957M
| $234K | ﹤0.01% |
5,134
+1,506
| +42% | +$68.6K |
|
1249
TopBuild
BLD
$11.9B
| $230K | ﹤0.01% |
3,205
+503
| +19% | +$36.1K |
|
1250
Cavco Industries
CVCO
$4.28B
| $229K | ﹤0.01% |
1,581
+137
| +9% | +$19.8K |
|